Why is Kilitch Drugs falling/rising?

As of 09-Sep, Kilitch Drugs (India) Ltd is experiencing a decline in its stock price, currently at Rs 360.60, which reflects a decrease of Rs 6.4 or 1.74%. The stock has underperformed its sector by 2.37% today and has been on a downward trend for the last two days, resulting in a total drop of 3.26% during this period. Despite a positive performance over the past week with a gain of 1.41%, the stock has seen a significant decline of 19.65% over the past month. It is noteworthy that the stock's current price is higher than its 5-day moving average but lower than its 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a notable increase in investor participation, with delivery volume rising by 545.09% against the 5-day average, indicating heightened trading interest.
In the broader market context, Kilitch Drugs' recent performance contrasts with the benchmark Sensex, which has gained 1.18% over the past week. While the stock has shown a year-to-date increase of 11.64%, its recent struggles highlight a stark difference compared to the benchmark's 3.79% gain in the same timeframe. The stock's performance over the last month and its consecutive falls suggest that investor sentiment may be shifting negatively, despite the overall liquidity being sufficient for trading. The absence of specific positive or negative factors further complicates the understanding of the stock's recent movements, leaving a gap in the analysis of potential catalysts for its price changes.